Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aposense Ltd.
DescriptionOral pro-drug analog of gemcitabine
Molecular Target
Mechanism of ActionDNA synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today